← Oncology Approval Tracker

FDA DECISION ·

Cyclophosphamide injection (Sandoz)

cyclophosphamide · Sandoz

FDA approvalNew formulationMultiple cancer types
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

A 100 mg/mL IV solution for labeled adult uses including malignant lymphomas, myeloma, leukemias, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma and breast carcinoma.

LAMPGEN ANALYSIS

Why it matters

The Sandoz solution added a new presentation of a longstanding alkylating treatment for multiple adult malignancies.

What research teams should watch

Verify concentration and excipients before preparation. The label limits pediatric use because of alcohol and propylene glycol content.

PRIMARY RECORDS

Sources